Cover Image

Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency

Saved in:

Bibliographic Details
Main Authors:	L. Mori (Author), Y.C. Ho (Author), B.C. Ramirez (Author), S. Valente (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity
by: M. Alexandra Carpenter, et al.
Published: (2021)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

HPLC - Quality by Design Approach for Simultaneous Detection of Torsemide, Spironolactone and Their Degradant Impurities
by: Bihola Unnati, et al.
Published: (2018)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)

PP 2.8 - 00124 Spironolactone Represses HIV-1 Driven Transcription in Human Microglia and T cell Models of Latency and Alters DNA Methylation of Metabolic Genes
by: A. Pang, et al.
Published: (2022)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
by: Elleard F.W. Heffern, et al.
Published: (2019)

Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents.
by: N. Beliakova-Bethell, et al.
Published: (2017)

9 LEDGIN-mediated inhibition of the IN-LEDGF/p75 interaction reduces provirus reactivation from latency
by: Zeger Debyser, et al.
Published: (2017)

OP 1.5 - 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment
by: L. Mori, et al.
Published: (2022)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

Using single-cell analysis and a primary model of HIV to study latency establishment and reactivation
by: L. De Armas, et al.
Published: (2019)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

Effects of heme degradation products on reactivation of latent HIV-1
by: Z. Melkova, et al.
Published: (2015)

Proteasomal degradation of PML protein is a stress response to HIV-1 replication and reactivation
by: I. Shytaj, et al.
Published: (2019)

Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
by: S. Moreno, et al.
Published: (2019)

Shining the RNA-Seq microscope on models of HIV latency
by: C.H. Woelk, et al.
Published: (2015)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017)

The HIV-1 antisense transcript AST is an inducer of viral latency
by: F. Romerio, et al.
Published: (2015)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

OA2-1 Frequent and 'burst-like' reactivation from latency in SIVmac239M infected macaques
by: M. Pinkevych, et al.
Published: (2016)

The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture
by: Anne Bruggemans, et al.
Published: (2023)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
by: J. Jacobson, et al.
Published: (2017)

Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
by: Song S, et al.
Published: (2024)

Gut and blood differ in mechanisms governing HIV transcription/latency
by: S. Telwatte, et al.
Published: (2017)

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir
by: J. Howard, et al.
Published: (2022)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

30 Changes in expression of small non-coding RNA during HIV infection and latency in a CD4+ T cell model of HIV latency
by: SaiVikram Vemula, et al.
Published: (2017)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

Whole genome sequencing of single HIV provirus and its proviral integration site for the study of HIV latency
by: C. Sun, et al.
Published: (2017)

DRESS syndrome secondary to spironolactone with atypical presentation
by: Anupama Bains, et al.
Published: (2020)

Spironolactone in hidradenitis suppurativa: a single-center
by: Rahul Masson, BS, et al.
Published: (2024)

Silencing of the GluN1-NMDA Glutamate Receptor Subunit by Intranasal siRNA Increases the Latency Time for Seizures in the Pilocarpine Rodent Model of Epilepsy
by: Raphaela Gonçalves Barros Perri, et al.
Published: (2022)